Ignacio Baselga-Carretero

6PUBLICATIONS
66CO-AUTHORS
Molecular targetsEvolution of developmental systemsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 21, 2026
Cellular neighborhoods govern antitumor T-cell infiltration following anti-CTLA-4 in melanoma with primary resistance to anti-PD-1.

|Feb 03, 2026
Methylation and merriment: an exploration of epigenetic mechanisms underlying play behaviour.

Robert J Malka, Marcos Arranz, Ignacio Baselga-Carretero

|Oct 23, 2023
Infusion Product TNFα, Th2, and STAT3 Activities Are Associated with Clinical Responses to Transgenic T-cell Receptor Cell Therapy.

Theodore S Nowicki, Cole W Peters, Crystal Quiros

|Aug 25, 2023
A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer.

Vina P Nguyen, Katie M Campbell, Theodore S Nowicki

|May 08, 2023
Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockade.

Luke Frankiw, Arun Singh, Cole Peters

|Sep 24, 2020
Autoantibody Landscape in Patients with Advanced Prostate Cancer.

William S Chen, Winston A Haynes, Rebecca Waitz

Pageof 1

Frequent Collaborators

4 joint publications

Antoni Ribas

3 joint publications

Theodore Scott Nowicki

2 joint publications

Ivan Perez Garcilazo

2 joint publications

Egmidio Medina